Command Palette

Search for a command to run...

NATCOPHARM
839.8(-0.71%)
1W: +6.32%

Natco Pharma Key Ratios

Cash Conversion Cycle

Latest:4.3 days

Return on Equity

Latest:28.0%

Return on Capital Employed

Latest:32.8%

Dupont Analysis

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
ROE12.71%11.27%4.06%15.66%25.88%27.98%
PAT margin42.56%34.72%26.42%8.74%21.49%24.06%
Asset Turnover0.46x0.44x0.45x0.54x0.69x0.62x
Leverage1.23x1.19x1.18x1.18x1.17x1.15x

Efficiency Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Inventory Days96.4118.8128.595.360.856.2
Receivable Days93.884.485.193.586.293.3
Payable Days243.3151.5106.4133.2136.4145.2
Cash Conversion Cycle-53.151.7107.255.710.54.3

Return Ratios

Analysis Summary

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
ROE12.71%11.27%4.06%15.66%25.88%27.98%
ROCE14.82%13.99%4.86%18.06%30.08%32.85%
ROA10.30%9.43%3.43%13.29%22.13%24.35%

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.